lifestyle.projectdiaspora.org

Author: CARIS MPI, INC., d/b/a CARIS LIFE SCIENCES

Caris Life Sciences Announces Launch of Caris ChromoSeq, the World’s First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies

May 2, 2026
Caris Life Sciences Advances Precision Oncology with New AI Insights Predicting Brain Metastases Risk in Breast and Lung Cancer

May 1, 2026
Caris Life Sciences to Present Six Oncology Studies Utilizing Proprietary Multimodal Data at the AACR Annual Meeting 2026

May 1, 2026
Caris Life Sciences Highlights the Importance of DPYD Testing in Colorectal Cancer During Colorectal Cancer Awareness Month

May 1, 2026
Caris Life Sciences Announces Another Breakthrough Study for GPSai in Identifying and Correcting Misdiagnosis of Cancer Patients

May 1, 2026
Caris Life Sciences Introduces Powerful New Caris AI Insights to Identify Early Platinum Resistance in Ovarian Cancer

April 30, 2026
Caris Life Sciences to Showcase Five Studies at the 2026 USCAP Annual Meeting

April 29, 2026
Caris Life Sciences Launches a Novel Caris AI Insights Signature to Guide First-Line Therapy Selection and Treatment De-Escalation in Pancreatic Cancer

April 29, 2026
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect

April 1, 2026
/C O R R E C T I O N — Caris Life Sciences/

February 27, 2026